DNAR-09. GB13 IS A POTENT NEOADJUVANT TREATMENT OPTION FOR IL13RA2-EXPRESSING GBM AND IMPROVES STANDARD-OF-CARE THERAPY

Authors: Harrison Laukhuff, Maija Woodruff, Randy Schrecengost

Published: 2024-11-11

DOI: 10.1093/neuonc/noae165.0460

Source: Full article

---

Abstract

Abstract